Complications Post-COVID-19 and Risk Factors Among Patients After Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study

    February 2022 in “ Epidemiologia ”
    Salvador Domènech-Montoliu, Joan Puig‐Barberà, María Rosario Pac-Sa, Paula Vidal-Utrillas, Marta Latorre-Poveda, Alba Del Rio-González, Sara Ferrando-Rubert, Gema Ferrer-Abad, Manuel Sánchez-Urbano, Laura Aparisi-Esteve, Gema Badenes-Marques, Belén Cervera-Ferrer, Ursula Clerig-Arnau, Claudia Dols-Bernad, María Fontal-Carcel, Lorna Gómez-Lanas, David Jovani-Sales, Maria Carmen León-Domingo, Maria Dolores Llopico-Vilanova, Mercedes Moros-Blasco, Cristina Notari-Rodríguez, Raquel Ruíz-Puig, Sonia Valls-López, Alberto Arnedo-Pena
    TLDR One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.
    This study, conducted in October 2020, analyzed 484 COVID-19 patients in Borriana, Spain, and found that 33.1% experienced at least one post-COVID-19 complication six months after infection. The most common persistent symptoms were hair loss (24.8%), fatigue, loss of smell or taste, and headache. Females, individuals 35 years or older, those with blood group B, current smokers, and those with at least one COVID-19 exposure were found to be at a higher risk for these complications. The study suggests the need for active medical follow-up of post-COVID-19 patients due to the prevalence of these persistent symptoms.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community BREEZULA COVID UPDATE: Filing for Special Protocol Assessment with FDA

      in Research/Science  61 upvotes 4 years ago
      The conversation discusses the progress of Clascoterone (Breezula) for hair loss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.

      community Why I deleted my YouTube channel Part I

      in Update  118 upvotes 3 years ago
      A YouTuber named Kevin, also known as Rider_Of_Roach, who deleted his YouTube channel due to personal attacks and controversy surrounding his views on hair loss treatments. He advocated for FDA-approved treatments like finasteride and minoxidil but faced backlash from those who disagreed with him. The conversation also discusses his past trolling behavior and a lawsuit he filed against a website that published false information about him. Despite some disagreements, many viewers appreciated his research-based content and hope to see him return in the future.

      community My strong recommendation for those shedding hair

      in Treatment  92 upvotes 3 years ago
      A user with aggressive male pattern baldness found that topical melatonin significantly reduced their hair shedding to 1 or 2 hairs per day and noticed some thickening of side hair. They tried many treatments like finasteride and minoxidil with little success, but topical melatonin showed immediate results in reducing hair loss.

    Similar Research

    5 / 1000+ results